Science Explorer Back to mapMap
Discussion
Company · Indianapolis · United States

Eli Lilly (United States)

In research, Eli Lilly (United States) stands highest in Health Sciences (#844 of 9,902 worldwide), Medicine (#831 of 8,541 worldwide) and Life Sciences (#814 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Endocrinology, Diabetes and Metabolism, Statistics and Probability and Psychiatry and Mental health (Endocrinology, Diabetes and Metabolism is 18.0× its share of world research).

lilly.comROR OpenAlex
World rank, 2022-now
#1,639
of 22,385 · #1,833 all time
Rank in United States
#325
of 3,332
Research works
15k
▼ 3% vs 2018-21
Citations
598k
40.0 per fractional work
Top-10% rate
16.1%
all institutions 10.0%
vs its own fields
1.07×
1.00× is exactly expected
Open access
28%
world 40%
International
16%
world 18%
Eli Lilly (United States)

What is Eli Lilly (United States) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #844 of 9,902 18.8%676 #844
MedicineField #831 of 8,541 18.7%649 #819
Life SciencesDomain #814 of 6,403 14.6%268 #998
Biochemistry, Genetics and Molecular BiologyField #727 of 2,964 12.7%165 #911
Physical SciencesDomain #3,248 of 10,670 9.9%145 #4181
Molecular BiologySubfield #676 of 1,880 10.8%101 #829
Endocrinology, Diabetes and MetabolismSubfield #140 of 349 19.1%113 #323
PhysiologySubfield #341 of 587 17.2%66 #639
Social SciencesDomain #8,155 of 9,585 10.5%66 #9202

Each strip is that field's whole ranked pool, with the notch where Eli Lilly (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Health Sciences#844 #844
  2. Medicine#819 #831
  3. Life Sciences#998 #814
  4. Biochemistry, Genetics and Molecular Biology#911 #727
  5. Physical Sciences#4,181 #3,248
  6. Molecular Biology#829 #676
  7. Endocrinology, Diabetes and Metabolism#323 #140
  8. Physiology#639 #341
  9. Social Sciences#9,202 #8,155
all time2022-now, better2022-now, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Which fields of science does Eli Lilly (United States) work in?

In 2022-now, 58% of research at Eli Lilly (United States) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (4%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 753 fractional works · 58.0% of its workMedicine: 721 fractional works · 55.5% of its workEndocrinology, Diabetes and Metabolism: 127 fractional works · 9.8% of its workPhysiology: 71 fractional works · 5.5% of its workPsychiatry and Mental health: 51 fractional works · 3.9% of its workOncology: 47 fractional works · 3.6% of its workSurgery: 45 fractional works · 3.5% of its workRheumatology: 43 fractional works · 3.3% of its workPulmonary and Respiratory Medicine: 41 fractional works · 3.2% of its workCardiology and Cardiovascular Medicine: 39 fractional works · 3.0% of its workRadiology, Nuclear Medicine and Imaging: 37 fractional works · 2.8% of its workEpidemiology: 31 fractional works · 2.4% of its workDermatology: 24 fractional works · 1.8% of its workPharmacology: 23 fractional works · 1.8% of its workNeurology: 19 fractional works · 1.5% of its workPathology and Forensic Medicine: 16 fractional works · 1.2% of its workGenetics: 14 fractional works · 1.1% of its workPublic Health, Environmental and Occupational Health: 12 fractional works · 0.9% of its workPediatrics, Perinatology and Child Health: 11 fractional works · 0.8% of its workInfectious Diseases: 10 fractional works · 0.8% of its workGastroenterology: 9 fractional works · 0.7% of its workFamily Practice: 8 fractional works · 0.6% of its workNephrology: 6 fractional works · 0.5% of its workHematology: 6 fractional works · 0.5% of its workImmunology and Allergy: 6 fractional works · 0.4% of its workUrology: 6 fractional works · 0.4% of its workHepatology: 4 fractional works · 0.3% of its workComplementary and alternative medicine: 4 fractional works · 0.3% of its workSmaller subfields together: 13 fractional works · 1.0% of its workHealth Professions: 25 fractional works · 1.9% of its workGeneral Health Professions: 10 fractional works · 0.8% of its workPharmacy: 7 fractional works · 0.5% of its workHealth Information Management: 3 fractional works · 0.2% of its workSmaller subfields together: 5 fractional works · 0.4% of its workVeterinary: 4 fractional works · 0.3% of its workSmall Animals: 4 fractional works · 0.3% of its workNursing: 2 fractional works · 0.2% of its workDentistry: 1 fractional works · 0.1% of its workLife Sciences: 307 fractional works · 23.6% of its workBiochemistry, Genetics and Molecular Biology: 191 fractional works · 14.7% of its workMolecular Biology: 118 fractional works · 9.1% of its workGenetics: 44 fractional works · 3.4% of its workCancer Research: 17 fractional works · 1.3% of its workCell Biology: 4 fractional works · 0.3% of its workBiotechnology: 3 fractional works · 0.2% of its workSmaller subfields together: 6 fractional works · 0.5% of its workImmunology and Microbiology: 55 fractional works · 4.2% of its workImmunology: 54 fractional works · 4.2% of its workSmaller subfields together: 1 fractional works · 0.1% of its workNeuroscience: 31 fractional works · 2.4% of its workNeurology: 9 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 8 fractional works · 0.6% of its workEndocrine and Autonomic Systems: 6 fractional works · 0.5% of its workCognitive Neuroscience: 5 fractional works · 0.4% of its workSmaller subfields together: 4 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 26 fractional works · 2.0% of its workPharmaceutical Science: 16 fractional works · 1.3% of its workPharmacology: 7 fractional works · 0.6% of its workSmaller subfields together: 2 fractional works · 0.1% of its workAgricultural and Biological Sciences: 3 fractional works · 0.2% of its workPhysical Sciences: 168 fractional works · 12.9% of its workMathematics: 41 fractional works · 3.2% of its workStatistics and Probability: 41 fractional works · 3.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 37 fractional works · 2.8% of its workOrganic Chemistry: 17 fractional works · 1.3% of its workSpectroscopy: 14 fractional works · 1.1% of its workSmaller subfields together: 6 fractional works · 0.4% of its workEngineering: 35 fractional works · 2.7% of its workBiomedical Engineering: 18 fractional works · 1.4% of its workControl and Systems Engineering: 4 fractional works · 0.3% of its workComputational Mechanics: 4 fractional works · 0.3% of its workMechanical Engineering: 3 fractional works · 0.2% of its workSmaller subfields together: 6 fractional works · 0.5% of its workComputer Science: 30 fractional works · 2.3% of its workComputational Theory and Mathematics: 13 fractional works · 1.0% of its workArtificial Intelligence: 10 fractional works · 0.8% of its workSmaller subfields together: 7 fractional works · 0.5% of its workMaterials Science: 10 fractional works · 0.8% of its workMaterials Chemistry: 7 fractional works · 0.5% of its workSmaller subfields together: 3 fractional works · 0.2% of its workEnvironmental Science: 10 fractional works · 0.7% of its workHealth, Toxicology and Mutagenesis: 4 fractional works · 0.3% of its workEnvironmental Chemistry: 3 fractional works · 0.2% of its workSmaller subfields together: 3 fractional works · 0.2% of its workChemical Engineering: 2 fractional works · 0.1% of its workPhysics and Astronomy: 2 fractional works · 0.1% of its workEarth and Planetary Sciences: 1 fractional works · 0.0% of its workEnergy: 1 fractional works · 0.0% of its workSocial Sciences: 72 fractional works · 5.5% of its workEconomics, Econometrics and Finance: 34 fractional works · 2.6% of its workEconomics and Econometrics: 32 fractional works · 2.4% of its workSmaller subfields together: 2 fractional works · 0.1% of its workDecision Sciences: 12 fractional works · 0.9% of its workStatistics, Probability and Uncertainty: 5 fractional works · 0.4% of its workManagement Science and Operations Research: 5 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.1% of its workPsychology: 11 fractional works · 0.9% of its workClinical Psychology: 5 fractional works · 0.4% of its workExperimental and Cognitive Psychology: 4 fractional works · 0.3% of its workSmaller subfields together: 3 fractional works · 0.2% of its workSocial Sciences: 10 fractional works · 0.8% of its workSociology and Political Science: 6 fractional works · 0.5% of its workSmaller subfields together: 4 fractional works · 0.3% of its workBusiness, Management and Accounting: 4 fractional works · 0.3% of its workArts and Humanities: 1 fractional works · 0.1% of its workALL ITS WORKEli Lilly (UnitedStates)1,299fractional works, 2022-now
Life Sciences24%Physical Sciences13%Health Sciences58%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 26 fields, with their numbers
    1. Medicine72155.5%
    2. Health Professions251.9%
    3. Veterinary40.3%
    4. Nursing20.2%
    5. Dentistry10.1%
    1. Biochemistry, Genetics and Molecular Biology19114.7%
    2. Immunology and Microbiology554.2%
    3. Neuroscience312.4%
    4. Pharmacology, Toxicology and Pharmaceutics262.0%
    5. Agricultural and Biological Sciences30.2%
    1. Mathematics413.2%
    2. Chemistry372.8%
    3. Engineering352.7%
    4. Computer Science302.3%
    5. Materials Science100.8%
    6. Environmental Science100.7%
    7. Chemical Engineering20.1%
    8. Physics and Astronomy20.1%
    9. Earth and Planetary Sciences10.0%
    10. Energy10.0%
    1. Economics, Econometrics and Finance342.6%
    2. Decision Sciences120.9%
    3. Psychology110.9%
    4. Social Sciences100.8%
    5. Business, Management and Accounting40.3%
    6. Arts and Humanities10.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Eli Lilly (United States) specialise in?

Where its research is concentrated relative to its size: Endocrinology, Diabetes and Metabolism takes 18.0× the share of its output that it takes of world research.

  1. Endocrinology, Diabetes and MetabolismSubfield · 126.7 works18×
  2. Statistics and ProbabilitySubfield · 41.0 works15×
  3. Psychiatry and Mental healthSubfield · 50.9 works7.9×
  4. RheumatologySubfield · 42.6 works7.2×
  5. DermatologySubfield · 23.9 works7.0×
  6. PhysiologySubfield · 71.2 works6.3×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.76× its world share, 191 worksBiochemistry, Geneti…Immunology and Microbiology: 4.21× its world share, 55 worksImmunology and Micro…Neuroscience: 1.49× its world share, 31 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.59× its world share, 26 worksPharmacology, Toxico…Chemical Engineering: 0.42× its world share, 2 worksChemical EngineeringChemistry: 1.81× its world share, 37 worksChemistryComputer Science: 0.29× its world share, 30 worksComputer ScienceEarth and Planetary Sciences: 0.03× its world share, 1 worksEarth and Planetary …Energy: 0.05× its world share, 1 worksEnergyEngineering: 0.18× its world share, 35 worksEngineeringEnvironmental Science: 0.15× its world share, 10 worksEnvironmental ScienceMaterials Science: 0.22× its world share, 10 worksMaterials ScienceMathematics: 2.71× its world share, 42 worksMathematicsPhysics and Astronomy: 0.06× its world share, 2 worksPhysics and AstronomyDentistry: 0.13× its world share, 1 worksDentistryHealth Professions: 0.73× its world share, 25 worksHealth ProfessionsMedicine: 2.89× its world share, 722 worksMedicineNursing: 0.33× its world share, 2 worksNursingVeterinary: 2.11× its world share, 4 worksVeterinaryArts and Humanities: 0.04× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.09× its world share, 4 worksBusiness, Management…Decision Sciences: 0.93× its world share, 12 worksDecision SciencesEconomics, Econometrics and Finance: 1.21× its world share, 34 worksEconomics, Econometr…Psychology: 0.28× its world share, 11 worksPsychologySocial Sciences: 0.06× its world share, 10 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.6×. Every wedge is a field page.

All 26 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics5.59×26 works
  2. Immunology and Microbiology4.21×55 works
  3. Medicine2.89×722 works
  4. Biochemistry, Genetics and Molecular Biology2.76×191 works
  5. Mathematics2.71×42 works
  6. Veterinary2.11×4 works
  7. Chemistry1.81×37 works
  8. Neuroscience1.49×31 works
  9. Economics, Econometrics and Finance1.21×34 works
  10. Decision Sciences0.93×12 works
  11. Health Professions0.73×25 works
  12. Chemical Engineering0.42×2 works
  13. Nursing0.33×2 works
  14. Computer Science0.29×30 works
  15. Psychology0.28×11 works
  16. Materials Science0.22×10 works
  17. Engineering0.18×35 works
  18. Environmental Science0.15×10 works
  19. Dentistry0.13×1 works
  20. Business, Management and Accounting0.09×4 works
  21. Physics and Astronomy0.06×2 works
  22. Social Sciences0.06×10 works
  23. Agricultural and Biological Sciences0.05×3 works
  24. Energy0.05×1 works
  25. Arts and Humanities0.04×1 works
  26. Earth and Planetary Sciences0.03×1 works

Who are the top researchers at Eli Lilly (United States)?

Ranked on the quality score, Steven M. Paul, Ruth E. Gimeno and Alexei Kharitonenkov lead among researchers whose main affiliation is Eli Lilly (United States).

  1. 1 Steven M. Paul United States · #19,165 worldwide 26k citations · 187 works
  2. 2 Ruth E. Gimeno United States · #25,620 worldwide 11k citations · 67 works
  3. 3 Alexei Kharitonenkov United States · #40,634 worldwide 18k citations · 96 works
  4. 4 Minrong Ai United States · #49,524 worldwide 3.2k citations · 130 works
  5. 5 Bruce Mitlak United States · #57,640 worldwide 16k citations · 144 works
  6. 6 David Raymond Ferry United States · #57,771 worldwide 17k citations · 155 works
  7. 7 Axel Haupt United States · #58,853 worldwide 11k citations · 188 works
  8. 8 William L. Macias United States · #59,065 worldwide 15k citations · 126 works
  9. 9 Kyle W. Sloop United States · #61,356 worldwide 7.9k citations · 142 works
  10. 10 Kevin L. Duffin United States · #68,283 worldwide 9.8k citations · 201 works
All ranked researchers at Eli Lilly (United States)

What are the most cited papers from Eli Lilly (United States)?

The most cited paper from Eli Lilly (United States) is "The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease" (Guy M. McKhann, David S. Knopman, Howard Mark Chertkow et al., 2011), with 19,132 citations. Next come "NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease" (10,885) and "Biological insights from 108 schizophrenia-associated genetic loci" (8,181).

Most cited papers
#PaperReleasedCitations
1 The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Guy M. McKhann, David S. Knopman, Howard Mark Chertkow et al. · Alzheimer s & Dementia Open access 22 Apr 2011 19,132
2 NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease Clifford R. Jack et al. · Alzheimer s & Dementia Open access Apr 2018 10,885
3 Biological insights from 108 schizophrenia-associated genetic loci Stephan Ripke et al. · Nature Open access297 authors Jul 2014 8,181
4 Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Reisa Anne Sperling et al. · Alzheimer s & Dementia Open access 22 Apr 2011 7,286
5 Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et al. · New England Journal of Medicine Open access 4 Nov 2007 6,822
All 60 most cited papers, with filters and sorting

Which keywords describe research at Eli Lilly (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Diabetes, Type 2 Diabetes, Obesity, Heart Failure, Cardiovascular Disease and Clinical Guidelines.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control101▲ 49×4 topics
  2. Epidemiology99▲ 1.92×72 topics
  3. Insulin Therapy91▲ 56×3 topics
  4. Inflammation82▲ 3.0×68 topics
  5. Cardiovascular Disease80▲ 5.4×33 topics
  6. Diabetes77▲ 12×17 topics
  7. Obesity73▲ 7.3×19 topics
  8. Type 2 Diabetes72▲ 24×5 topics
  9. Heart Failure69▲ 12×13 topics
  10. Biomarkers61▲ 6.8×16 topics
  11. Clinical Guidelines58▲ 15×8 topics
  12. Monoclonal Antibodies55▲ 47×3 topics
  13. Oxidative Stress54▲ 2.5×44 topics
  14. Cardiovascular Outcomes52▲ 70×1 topic
  15. Glucose Control52▲ 70×1 topic
  16. Metabolic Syndrome52▲ 4.9×20 topics
  17. Alzheimer's Disease46▲ 13×8 topics
  18. Genetics44▲ 4.8×17 topics
  19. Cardiovascular Risk43▲ 11×9 topics
  20. Weight Loss43▲ 21×4 topics
  21. Neurological Disorders42▲ 5.7×19 topics
  22. Neuroinflammation41▲ 11×6 topics
  23. Clinical Trials41▲ 4.7×16 topics
  24. Therapeutic Antibodies41▲ 45×2 topics
  25. Inflammatory Bowel Disease40▲ 26×5 topics
  26. Type 1 Diabetes38▲ 34×2 topics
  27. Neurodegeneration37▲ 9.2×8 topics
  28. Complications35▲ 5.4×9 topics
  29. Biopharmaceuticals34▲ 51×3 topics
  30. Immunogenicity34▲ 60×3 topics
  31. Insulin Resistance33▲ 5.6×10 topics
  32. Lifestyle Intervention32▲ 27×2 topics
  33. Neuroimaging32▲ 8.8×8 topics
  34. Autoantibodies31▲ 10×8 topics
  35. Continuous Glucose Monitoring30▲ 51×1 topic
  36. Glycosylation30▲ 21×3 topics
  37. Hypoglycemia30▲ 51×1 topic
  38. Immunology29▲ 20×2 topics
  39. Atherosclerosis29▲ 7.7×11 topics
  40. Bayesian Methods27▲ 41×2 topics

Which research topics does Eli Lilly (United States) publish most on?

By volume in 2022-now: Diabetes Treatment and Management, Diabetes Management and Research, Alzheimer's disease research and treatments and Dementia and Cognitive Impairment Research.

Diabetes Treatment and Management: 52 fractional worksDiabetes Management and Research: 30 fractional worksAlzheimer's disease research and treatments: 26 fractional worksDementia and Cognitive Impairment Research: 26 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 24 fractional worksInflammatory Bowel Disease: 24 fractional worksMonoclonal and Polyclona…22Monoclonal and Polyclonal Antibodies Research: 22 fractional worksStatistical Methods in C…20Statistical Methods in Clinical Trials: 20 fractional worksProtein purification and…18Protein purification and stability: 18 fractional worksPsoriasis: Treatment and…17Psoriasis: Treatment and Pathogenesis: 17 fractional works
Endocrinology, Diabetes and MetabolismPhysiologyPsychiatry and Mental healthEconomics and Econometrics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 52 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 30 works
  3. 3 Alzheimer's disease research and treatments Physiology 26 works
  4. 4 Dementia and Cognitive Impairment Research Psychiatry and Mental health 26 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 24 works
  6. 6 Inflammatory Bowel Disease Genetics 24 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 22 works
  8. 8 Statistical Methods in Clinical Trials Statistics and Probability 20 works
  9. 9 Protein purification and stability Molecular Biology 18 works
  10. 10 Psoriasis: Treatment and Pathogenesis Immunology 17 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.5%not open72.5%

World: 40% of research is openly available.

with international co-authors16.3%domestic only83.7%

World: 18% is written across borders.

How has Eli Lilly (United States)'s research output changed?

Output in 2022-2025 was 3% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Eli Lilly (United States) as a percentage of every work published that year, 0.0049% in 2024.

still counting0.020%0.040%0.060%Eli Lilly (United States)0.0056% in 202519801990200020102020

Fractional works of Eli Lilly (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%Eli Lilly (United States)17.4% in 2025all institutions10.0% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.4% in 2025.

Other research institutions in Indianapolis

All research institutions in Indianapolis

Share Eli Lilly (United States)'s ranking

Eli Lilly (United States) on Science Explorer

A card with Eli Lilly (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website2Each links back here and updates with every snapshot

Its overall standing, then the domains, fields and subfields where Eli Lilly (United States) is in the world's top ten or its top 1%. Each has an image of its own.

Overall

Domains

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Eli Lilly (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.